Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Net-Income-From-Continuing-Operations" stands at 2.60 Billion Swiss Francs for the trailing twelve months (TTM) period ending 09/30/2020, the lowest value at least since 06/30/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -80.26 percent compared to the value the year prior.
The 1 year change in percent is -80.26.
The 3 year change in percent is -63.87.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income From Continuing Operations | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income From Continuing Operations | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income From Continuing Operations | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Net Income From Continuing Operations | 280,205,508,085.11 |
![]() | Novartis AG - Net Income From Continuing Operations | 255,096,620,580.91 |